DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $807,317 | +7.6% | 3,254 | +4.1% | 0.04% | +7.5% |
| Q2 2023 | $750,480 | -11.3% | 3,127 | -6.8% | 0.04% | -16.7% |
| Q1 2023 | $845,846 | -4.6% | 3,356 | +0.5% | 0.05% | -7.7% |
| Q4 2022 | $886,503 | -0.5% | 3,340 | -3.1% | 0.05% | -11.9% |
| Q3 2022 | $891,000 | +3.4% | 3,448 | +1.4% | 0.06% | +9.3% |
| Q2 2022 | $862,000 | -12.0% | 3,401 | +1.9% | 0.05% | -15.6% |
| Q1 2022 | $979,000 | -6.9% | 3,337 | +4.4% | 0.06% | -4.5% |
| Q4 2021 | $1,052,000 | +5.6% | 3,197 | -2.3% | 0.07% | -2.9% |
| Q3 2021 | $996,000 | +18.9% | 3,272 | +4.8% | 0.07% | +4.5% |
| Q2 2021 | $838,000 | +18.4% | 3,123 | -0.7% | 0.07% | -57.7% |
| Q1 2021 | $708,000 | +1.1% | 3,146 | -0.2% | 0.16% | -9.3% |
| Q4 2020 | $700,000 | +10.4% | 3,151 | +7.1% | 0.17% | -10.4% |
| Q3 2020 | $634,000 | +23.1% | 2,943 | +1.0% | 0.19% | +23.9% |
| Q2 2020 | $515,000 | +33.4% | 2,915 | +4.4% | 0.16% | +4.0% |
| Q1 2020 | $386,000 | -13.5% | 2,792 | -3.8% | 0.15% | +8.8% |
| Q4 2019 | $446,000 | -8.4% | 2,903 | -13.9% | 0.14% | -26.3% |
| Q3 2019 | $487,000 | +17.3% | 3,370 | +16.1% | 0.19% | +13.4% |
| Q2 2019 | $415,000 | +8.4% | 2,903 | 0.0% | 0.16% | +13.1% |
| Q1 2019 | $383,000 | +36.3% | 2,903 | +6.4% | 0.14% | +13.3% |
| Q4 2018 | $281,000 | -4.1% | 2,728 | +1.2% | 0.13% | +11.3% |
| Q3 2018 | $293,000 | +10.2% | 2,695 | 0.0% | 0.12% | +8.5% |
| Q2 2018 | $266,000 | +0.4% | 2,695 | 0.0% | 0.11% | +24.7% |
| Q1 2018 | $265,000 | -2.2% | 2,695 | -8.3% | 0.08% | -3.4% |
| Q4 2017 | $271,000 | +9.7% | 2,940 | +1.7% | 0.09% | +20.5% |
| Q3 2017 | $247,000 | +1.2% | 2,890 | 0.0% | 0.07% | +1.4% |
| Q2 2017 | $244,000 | -1.2% | 2,890 | 0.0% | 0.07% | 0.0% |
| Q1 2017 | $247,000 | -3.1% | 2,890 | -11.8% | 0.07% | -1.4% |
| Q4 2016 | $255,000 | -32.5% | 3,275 | -26.4% | 0.07% | -80.6% |
| Q1 2015 | $378,000 | – | 4,450 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |